As announced on 18 January 2012, pharmaceutical company Nycomed will cut 1,200 out of 2,500 jobs in Germany, 700 of them at its research site in Konstanz. The sale sites in Aachen and Konstanz will be closed and relocated to Berlin. Additionally, 400 sales representatives will lose their jobs.
Nycomed was acquired by Takeda, a Japanese global pharmaceutical company, in September 2011. The announced job cuts are part of the ‘integration' of Nycomed. In addition to the acquisition, reasons for the announced redundancies are changes in the German pharmaceutical market and expiring of patents.
The new restructuring programme is expected to save some 2 billion euro by 2015.